News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Expedeon Inc Release: TruePrime Liquid Biopsy Kit Is A Ready To Use Amplification Kit For Cell-Free DNA



11/17/2016 10:27:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
TruePrime™ LB address the current liquid biopsy sensitivity and specificity issues by utilizing the adapted amplification of cancer specific large fragment cfDNA based on primer-free TruePrime™ technology based on the combination of the enzyme TthPrimPol and Phi29 DNA polymerase.

TruePrime™ mediated circulating tumor DNA (ctDNA) amplification specifically amplifies and selects the larger, more cancer-specific, DNA fragment size population from human plasma. Consequently, TruePrime™ LB provides a method for assessing cancer genome information from all patients, regardless of tumor burden, with superior sensitivity and specificity, reliable at 100 pg of total cfDNA while preserving the single nucleotide variants (SNVs) and SNV frequencies across different sequencing technologies and allowing the amplification of cfDNA to levels than permit sequencing.

TruePrime™ LB provides a screening method for de-novo detection of cancer or reoccurrence of cancer based on a threshold of amplified DNA obtainable within a certain reaction time frame. The method of detecting cancer is further enhanced by providing a test for the presence of human DNA derived from larger fragments based on a panel of PCR primers, for example the CovCheck™ kit, which SYGNIS launched worldwide in October this year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES